What is the current Price Target for the Inovio Pharmaceuticals, Inc. stock?

The average Inovio Pharmaceuticals, Inc. target price is $3.06. This is 166.09% higher than the current stock price. The highest price target is 265.22%, the lowest is 119.57%. 4 Analysts have issued a price target Inovio Pharmaceuticals, Inc. 2027 .

How high will the Inovio Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Inovio Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Inovio Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Inovio Pharmaceuticals, Inc. stock today?

The performance of Inovio Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Inovio Pharmaceuticals, Inc. stock fall?

The decline in Inovio Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Inovio Pharmaceuticals, Inc. Forecast, price target & analysts

$1.15

0.86%

Nasdaq, Oct 05, 04:23 pm EDT. Closed.

ISIN

US45773H2013

Symbol

INO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Inovio Pharmaceuticals, Inc. Target price 2026 - Analyst rating & recommendation

Inovio Pharmaceuticals, Inc. Classifications & Recommendation

Buy

75%

Hold

25%

Inovio Pharmaceuticals, Inc. Price Target

Target Price	$3.06
Price	$1.15
Potential	166.09% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Inovio Pharmaceuticals, Inc. 2027 . The average Inovio Pharmaceuticals, Inc. target price is $3.06. This is 166.09% register free of charge higher than the current stock price. The highest price target is $4.20 265.22% register free of charge , the lowest is $2.53 119.57% register free of charge .
	A rating was issued by 8 analysts: 6 Analysts recommend Inovio Pharmaceuticals, Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Inovio Pharmaceuticals, Inc. stock has an average upside potential 2027 of 166.09% register free of charge . Most analysts recommend the Inovio Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.81	-0.81
	54.18%	55.25%
P/E		negative
EV/Sales		123.67

4 Analysts have issued a Inovio Pharmaceuticals, Inc. forecast for earnings per share. The average Inovio Pharmaceuticals, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.81	54.18%
2026	$-0.81 55.25% unlock
2027	$-0.44 45.68% unlock
2028	$-0.11 75.00% unlock
2029	$0.47 527.27% unlock
2030	$0.63 34.04% unlock
2031	$1.06 68.25% unlock
2032	$1.11 4.72% unlock
2033	$1.20 8.11% unlock

Current	-1.41	28.92%
2026	-1.42 0.38% unlock
2027	-2.63 85.21% unlock
2028	-10.44 296.96% unlock

Inovio Pharmaceuticals, Inc....

Current Inovio Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Jefferies	Locked ➜ Locked	Locked	Aug 13 2026
Piper Sandler	Locked ➜ Locked	Locked	Aug 03 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 01 2026
Piper Sandler	Locked ➜ Locked	Locked	Nov 14 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 14 2025
Piper Sandler	Locked ➜ Locked	Locked	Jul 09 2025
Oppenheimer	Locked ➜ Locked	Locked	May 14 2025

Analyst Rating	Date
Locked Jefferies: Locked ➜ Locked	Aug 13 2026
Locked Piper Sandler: Locked ➜ Locked	Aug 03 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 01 2026
Locked Piper Sandler: Locked ➜ Locked	Nov 14 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 14 2025
Locked Piper Sandler: Locked ➜ Locked	Jul 09 2025
Locked Oppenheimer: Locked ➜ Locked	May 14 2025

Discover more stocks with a high price target

NIO ADR 84.17%

Alibaba Group Holding Ltd 80.17%

Rheinmetall 66.50%

Tencent Holdings Ltd. 60.60%

Adyen 56.10%

BYD 49.89%

Uber Technologies 48.27%

TUI 46.72%

Infineon 45.44%

Siemens Energy 43.75%

Adidas 43.36%

Netflix 42.80%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now